Khaitov M 1

1. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
2. Management of anaphylaxis due to COVID-19 vaccines in the elderly
3. Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference
4. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
1